equityflowunderstand the flow and follow it
EquityFlow › Companies › NADMED

NADMED

biotech · Helsinki, FI

Biotech making CE-marked kits measuring NAD and glutathione levels from blood.

In the network

Shares the most investors with (number = shared investors):
CubaseBio 2

Funding history

DateRoundAmount
Aug 2024Series A
NADMED raised a €3.5M Series A led by Nordic Science Investments to enter the US and expand its NAD testing technology.
$3.5M

Investors

Tap an investor to see what else they have backed.

Nordic Science InvestmentsVoima Ventures

Other companies in biotech

Antag TherapeuticsAdcendoFreya BiosciencesTXN SystemsPromise BioConcinnity GeneticsNoema PharmaMabGenesisRadioNano TherapeuticsCitryllAlveron PharmaAQEMIA

Other companies in FI

RotomateAavuusGranarium TechnologiesICEYESkyforaResandAvreaSteady EnergySpacentGeyser BatteriesCeLLife TechnologiesRebelvolt

Other companies at Series A stage

&Done&Open011h01Health1000 Satellites100ms11x.ai12 Pharmacy180° Seguros1X Technologies1k Kirana Bazaar207
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.